Scott Thomas Smith
Förmögenhet: 978 688 $ per 2026-05-31
Förmögenhet: 978 688 $ per 2026-05-31
Scott Thomas Smith is Chief Financial Officer & Executive Vice President at Ascendis Pharma, Inc. since 2016.
Mr. Smith is Chief Financial Officer & Executive Vice President at Ascendis Pharma A since 2023.
Formerly, Mr. Smith was Director-Healthcare Investment Banking Group at Wedbush Securities, Inc. from 2012 to 2016.
Mr. Smith was Director-Global Healthcare Investment Banking at Merrill Lynch, Pierce, Fenner & Smith, Inc. Education includes an undergraduate degree from Claremont McKenna College and an MBA from Stanford Graduate School of Business.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ASCENDIS PHARMA A/S -.--% | 2026-06-02 | 4 367 ( -.--% ) | 978 688 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| ASCENDIS PHARMA A/S | Finansdirektör/CFO | 2016-08-08 |
Ascendis Pharma, Inc.
Ascendis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops endocrinology, rare disease and oncology medicines & transient conjugation platform | Finansdirektör/CFO | 2016-08-01 |
| Företag | Position | Slut |
|---|---|---|
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Företagsledare/Principal | 2016-01-01 |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Finance |
Claremont McKenna College
Claremont McKenna College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Stanford Graduate School of Business
Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma, Inc.
Ascendis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops endocrinology, rare disease and oncology medicines & transient conjugation platform | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån